Dr. Sinisa Dovat, MD, PhD

Media Releases

Advancing Cancer Research and Treatment through Innovative Gene Regulation Studies 

Hershey, Pennsylvania – Penn State Health Children’s Hospital and Penn State Cancer Institute proudly announce Dr. Sinisa Dovat, as a leading physician-scientist and pediatric hematologist-oncologist dedicated to transforming the landscape of childhood cancer treatment. With a robust academic and clinical background, Dr. Dovat is making significant strides in understanding the genetic underpinnings of cancer, particularly through his work with the gene Ikaros.

As a Professor and Vice Chair for Basic Science Research in the Department of Pediatrics at Penn State College of Medicine, Dr. Dovat plays a pivotal role in its Division of Pediatric Hematology and Oncology. In addition to his leadership in the Four Diamonds Pediatric Cancer Research Center, he holds multiple professorships in the Departments of Biochemistry, Molecular Biology, and Pharmacology. His extensive expertise culminates in his position as the Four Diamonds Endowed Chair and Director of Translational Research in the Pediatric Experimental Therapeutics Program, where he has championed innovative approaches to pediatric cancer treatment since 2010.

Dr. Dovat’s laboratory is internationally recognized for its groundbreaking research into how specific gene abnormalities contribute to pediatric cancers. Central to his work is the exploration of the Ikaros gene, which is crucial for regulating other genes involved in leukemia. Research indicates that the absence of Ikaros in patients' cells can lead to the development of high-risk childhood leukemia, characterized by poor treatment outcomes. 

Understanding the role of Ikaros offers promising avenues for developing targeted therapies. Dr. Dovat’s lab is focused on elucidating the mechanisms by which Ikaros controls leukemia cell growth, with the ultimate goal of designing new, effective drugs that target this critical gene. His translational research aims to bridge the gap between laboratory discoveries and clinical applications, ensuring that advancements in understanding basic cancer biology lead to improved therapeutic strategies and agents.

Educated in Serbia, Dr. Dovat earned his Medical Degree from the Faculty of Medicine at the University of Novi Sad before relocating to the United States. He completed his residency in pediatrics at Penn State Milton S. Hershey Medical Center from 1993 to 1996 and continued his fellowship in pediatric hematology/oncology at UCLA Medical Center from 1996 to 1999. 

Board certified and recognized as a Diplomate of the American Board of Pediatrics, Dr. Dovat is committed to advancing the field of pediatric oncology through both clinical practice and innovative research. His dedication extends to mentoring the next generation of medical professionals and contributing to groundbreaking advancements in patient care.

Recommended Articles

• Superheroes Unite For Elementary Student Fighting Lymphoma

  Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...

• Daughter's Donation Gives Mom with Lymphoma a Fighting Chance

  Chyanne Ojageer, a 14-year-old teenager from Kissimmee, Florida, became one of the youngest bone marrow donors in the state when she donated her own bone marrow to help save her mother’s life.Neisha Ojageer, never in her wildest dreams thought that her daughter would be the person to save her...

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• Inspirational Blood Cancer Survivors

  Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...

• Life Lessons After Multiple Misdiagnoses of Lymphoma

  28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...

• How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma

  Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...